dr. eng on roles of regorafenib and tas-102 in crc treatment
Published 6 years ago • 198 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
7:54
regorafenib vs tas-102 salvage therapy
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
11:24
managing toxicities associated with regorafenib
-
1:39
dr. hochster on the safety analysis of tas-102 in crc and gastric/gej cancer
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:05
dr. corcoran on the utility of regorafenib in crc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:04
dr. eckhardt on the role of regorafenib in colorectal cancer
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
0:50
dr. wu on possible combinations with tas-102 in crc
-
9:34
regorafenib in colorectal cancer